Fig. 2From: Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)Durability of dual and triple combined antiretroviral regimens containing darunavir/cobicistat (DRV/c). Patients were censored when stopping DRV/cBack to article page